<?xml version="1.0" encoding="UTF-8"?>
<html xmlns:fo="http://www.w3.org/1999/XSL/Format"
	xmlns:xi="http://www.w3.org/2001/XInclude">
<head>
<meta xmlns="http://www.w3.org/1999/xhtml" http-equiv="Content-Type"
	content="text/html; charset=utf-8" />
<style type="text/css">
@media screen {
	.test-story-main legend {
		text-align: center;
		font-size: 110%;
		font-weight: bold;
	}
	.test-story-main .nav-tabs {
		font-weight: bold;
	}
	.test-story-main .tds_obxGrpSpl {
		background: #B8B8B8;
	}
	.test-story-main maskByMediaType {
		display: table;
	}
	.test-story-main table tbody tr th {
		font-size: 95%
	}
	.test-story-main table tbody tr td {
		font-size: 110%;
	}
	.test-story-main table tbody tr th {
		text-align: left;
		background: #C6DEFF;
		font-size: 100%;
	}
	.test-story-main fieldset {
		text-align: center;
	}
	.test-story-main table {
		width: 98%;
		border: 1px groove;
		table-layout: fixed;
		margin: 0 auto;
		border-collapse: collapse;
	}
	.test-story-main table tr {
		border: 2px groove;
	}
	.test-story-main table th {
		border: 2px groove;
	}
	.test-story-main table td {
		border: 1px groove;
	}
	.test-story-main table thead {
		border: 1px groove;
		background: #446BEC;
		text-align: center;
	}
	.test-story-main .separator {
		background: rgb(240, 240, 255);
		text-align: left;
	}
	.test-story-main table tbody tr td {
		text-align: left
	}
	.test-story-main .noData {
		background: #B8B8B8;
	}
	.test-story-main .childField {
		background: #B8B8B8;
	}
	.test-story-main .title {
		text-align: left;
	}
	.test-story-main h3 {
		text-align: center;
		page-break-inside: avoid;
	}
	.test-story-main h2 {
		text-align: center;
	}
	.test-story-main h1 {
		text-align: center;
	}
	.test-story-main .pgBrk {
		padding-top: 15px;
	}
	.test-story-main .er7Msg {
		width: 100%;
	}
	.test-story-main .embSpace {
		padding-left: 15px;
	}
	.test-story-main .accordion-heading {
		font-weight: bold;
		font-size: 90%;
	}
	.test-story-main .accordion-heading i.fa:after {
		content: "\00a0 ";
	}
	.test-story-main panel {
		margin: 10px 5px 5px 5px;
	}
}

@media print {
	.test-story-main legend {
		text-align: center;
		font-size: 110%;
		font-weight: bold;
	}
	.test-story-main .nav-tabs {
		font-weight: bold;
	}
	.test-story-main .obxGrpSpl {
		background: #B8B8B8;
	}
	.test-story-main maskByMediaType {
		display: table;
	}
	.test-story-main table tbody tr th {
		font-size: 90%
	}
	.test-story-main table tbody tr td {
		font-size: 90%;
	}
	.test-story-main table tbody tr th {
		text-align: left;
		background: #C6DEFF;
	}
	.test-story-main table thead tr th {
		text-align: center;
		background: #4682B4;
	}
	.test-story-main fieldset {
		text-align: center;
		page-break-inside: avoid;
	}
	.test-story-main table {
		width: 98%;
		border: 1px groove;
		table-layout: fixed;
		margin: 0 auto;
		page-break-inside: avoid;
		border-collapse: collapse;
	}
	.test-story-main table tr {
		border: 2px groove;
	}
	.test-story-main table th {
		border: 2px groove;
	}
	.test-story-main table td {
		border: 1px groove;
	}
	.test-story-main table thead {
		border: 1px groove;
		background: #446BEC;
		text-align: left;
	}
	.test-story-main .separator {
		background: rgb(240, 240, 255);
		text-align: left;
	}
	.test-story-main table tbody tr td {
		text-align: left;
	}
	.test-story-main .noData {
		background: #B8B8B8;
	}
	.test-story-main .childField {
		background: #B8B8B8;
	}
	.test-story-main .tds_title {
		text-align: left;
		margin-bottom: 1%
	}
	.test-story-main h3 {
		text-align: center;
	}
	.test-story-main h2 {
		text-align: center;
	}
	.test-story-main h1 {
		text-align: center;
	}
	.test-story-main .tds_pgBrk {
		page-break-after: always;
	}
	.test-story-main #er7Message table {
		border: 0px;
		width: 80%
	}
	.test-story-main #er7Message td {
		background: #B8B8B8;
		font-size: 65%;
		margin-top: 6.0pt;
		border: 0px;
		text-wrap: preserve-breaks;
		white-space: pre;
	}
	.test-story-main .er7Msg {
		width: 100%;
		font-size: 80%;
	}
	.test-story-main .er7MsgNote {
		width: 100%;
		font-style: italic;
		font-size: 80%;
	}
	.test-story-main .embSpace {
		padding-left: 15px;
	}
	.test-story-main .embSubSpace {
		padding-left: 25px;
	}
	.test-story-main .accordion-heading {
		font-weight: bold;
		font-size: 90%;
	}
	.test-story-main .accordion-heading i.fa:after {
		content: "\00a0 ";
	}
	.test-story-main panel {
		margin: 10px 5px 5px 5px;
	}
}
</style>
</head>
<body>
	<!-- generated by TestStory_v1.xslt Version:1.0   Profile:TestStory-->
	<fieldset>
		<div class="test-story-main">
			<table><tr><th>Description</th></tr><tr><td><p>Administering Practitioner Daniela Jennifer Wyatt continues the process of fulfilling Dr. Ramon Michael Bradshaw&#39;s vaccine order for Alexandria Montoya (DOB: 03/27/2012).</p><p><br>Daniela Jennifer Wyatt recalls there was only one potent (i.e., not expired) GARDASIL 9 - HPV9 product in the vaccine storage unit (Lot Number IIPVAXN08).</p><p><br>Daniela Jennifer Wyatt notes that lot number IIPVAXN08 for GARDASIL 9 - HPV9 was paid for using Private funds which conflicts with the vaccine program eligibility for Alexandria Montoya (DOB: 03/27/2012), VFC eligible - Medicaid/Medicaid Managed Care</p><p><br>After determining infrequent replenishment is allowed by the State VFC Program and to ensure the patient begins the HPV9 series, Daniela Jennifer Wyatt decides to use lot number IIPVAXN08 for today&#39;s visit and replace the privately funded vaccine after the next VFC vaccine order is received.<br><br></p><p><br></p></td></tr></table><br/><table><tr><th>Pre-condition</th></tr><tr><td><p>(1) The patient, Alexandria Jacqueline Montoya (DOB 03/27/2012), is registered in the SUT.</p><p>(2) Two vaccine items are stored in the clinic&#39;s vaccine storage unit, both for GARDASIL 9 (HPV 9), one is publicly funded and expired (Lot Number IIPVAXN09) and the other (Lot Number IIPVAXN08) is privately funded and unexpired (i.e., still potent).</p><p>(3) Dr. Bradshaw has ordered an HPV9 vaccine for Alexandria Jacqueline Montoya (DOB 03/27/2012). in step 3.10.2</p><p>(4) Daniela Jennifer Wyatt, the administering practitioner, has opened the SUT&#39;s records for Alexandria Jacqueline Montoya (DOB 03/27/2012).</p><p>(5) Infrequent replenishment is allowed by the State VFC Program.</p><p><br></p></td></tr></table><br/><table><tr><th>Post-Condition</th></tr><tr><td><p>The SUT makes the mismatch of the vaccine product&#39;s funding source and the patient&#39;s vaccine program eligibility visually apparent to the administering practitioner or does not permit the administering practitioner from selecting the mismatched vaccine.</p><p><br>Alexandria Jacqueline Montoya (DOB 03/27/2012) is vaccinated with GARDASIL 9 - HPV9 lot number IIPVAXN08, and this information is incorporated into the SUT.<br><br></p><p>Go to step 5.7.1 to transmit this vaccine administration.</p></td></tr></table><br/><table><tr><th>Test Objectives</th></tr><tr><td><p>To test the capability that the SUT allows the administering practitioner be aware of a mismatch of the vaccine product&#39;s funding source and the patient&#39;s vaccine program eligibility.</p><p><br></p></td></tr></table><br/><table><tr><th>Evaluation Criteria</th></tr><tr><td><p>The SUT distinguishes the publicly funded vaccine dose from the privately funded doses and is visually apparent to the administering practitioner. Alternatively, the SUT may prevent publicly funded vaccine doses from being visible or selected by users.</p><p>The selection workflow includes clear evidence of a vaccine funding source in at least one of the following ways (only 1 method is required):</p><ul><li>Passive: The vaccine product that is privately funded is not displayed by the SUT (i.e., cannot be chosen)</li><li>Passive: The display of selectable vaccine products which includes the funding source are displayed with some indication that choosing the wrong funding sourced product is discouraged (e.g., hover over tooltip, color, bolding, graying out, or other UI indication used by the SUT for similar issues)</li><li>Active: Selection of a specific privately funded vaccine product to administer generates informative messages in a method consistent with the SUT for similar issues) - Active informing</li></ul><p>The SUT makes the mismatch of the vaccine product&#39;s funding source and the patient&#39;s vaccine program eligibility visually apparent to the administering practitioner or does not permit the administering practitioner from selecting the mismatched vaccine.</p><table border="0" cellpadding="0" cellspacing="0" width="717"><tbody><tr height="20"><td height="20" width="303">Vaccine Funding Source</td><td width="414">Private funds</td></tr><tr height="40"><td height="40" width="303">Patient Dose-level Eligibility for Vaccines for Children</td><td>VFC eligible - Medicaid/Medicaid Managed Care</td></tr></tbody></table><p><br></p><p>The SUT may meet the requirement by prohibiting the selection of mismatch. However, careful consideration should be made when implementing such a strategy. This may result in patients not being immunized in a timely manner.<br><br>The following information is a not evaluated portion of this test step but supports subsequent test steps and should be performed by the SUT user:<br><br>Alexandria Jacqueline Montoya (DOB 03/27/2012) is administered vaccines by Nurse Daniela Jennifer Wyatt who enters the following information into the SUT:</p><table border="0" cellpadding="0" cellspacing="0" width="717"><tbody><tr height="40"><td height="40" width="303">Product Name (This may vary with each implementation)</td><td width="414">GARDASIL 9 00006-4121-01</td></tr><tr height="20"><td height="20">Date Administered</td><td>Today&#39;s Date</td></tr><tr height="20"><td height="20">Unit-of-Use (Syringe or Vial) NDC</td><td width="414">00006-4121-01</td></tr><tr height="20"><td height="20">Manufacturer</td><td width="414">Merck and Co., Inc.</td></tr><tr height="20"><td height="20">Lot Number</td><td width="414">IIPVAXN08</td></tr><tr height="20"><td height="20">Expiration Date</td><td width="414">09/27/2029</td></tr><tr height="20"><td height="20"><br></td><td width="414"><br></td></tr><tr height="89"><td height="89" width="303">Unit-of-Use (Vial/Syringe) Image that may be scanned.</td><td align="left" valign="top"><table cellpadding="0" cellspacing="0"><tbody><tr><td height="89" width="414"><img src="data:image/png;base64,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" alt="" class="fr-dii fr-draggable" style="width: 59px; height: 59px;"><br></td></tr></tbody></table></td></tr><tr height="20"><td height="20">GTIN 00300064121018</td><td><br></td></tr><tr height="46"><td height="46" width="303">Patient Dose-level Eligibility for Vaccines for Children</td><td>VFC eligible - Medicaid/Medicaid Managed Care</td></tr><tr height="20"><td height="20" width="303">Vaccine Funding Source</td><td>Private funds</td></tr><tr height="20"><td height="20">Route</td><td>INTRAMUSCULAR</td></tr><tr height="20"><td height="20">Site</td><td>Left Deltoid</td></tr><tr height="20"><td height="20">VIS Given</td><td>HPV (Human Papillomavirus) Vaccine VIS - 08/06/2021</td></tr><tr height="20"><td height="20">CVX</td><td>165</td></tr><tr height="20"><td height="20">MVX</td><td>MSD</td></tr><tr height="21"><td height="21" width="303"><br></td><td><br></td></tr><tr height="21"><td height="21" width="303">Funding Source Code</td><td>PHC70</td></tr><tr height="21"><td height="21" width="303">Packaging</td><td>10 pack &ndash; 1 dose syringe</td></tr><tr height="21"><td height="21" width="303">Trade Name</td><td>GARDASIL 9</td></tr><tr height="21"><td height="21" width="303">Generic Name (CVX 165)</td><td width="414">HPV9</td></tr></tbody></table></td></tr></table><br/><table><tr><th>Notes</th></tr><tr><td><p>The VIS encoded value that is associated with the most current VIS for the vaccines and evaluated in the transmit message, can be found in the CDC VIS Lookup Table located here: <a href="https://www.cdc.gov/vaccines/programs/iis/code-sets/vis-barcode-lookup-table.html">https://www.cdc.gov/vaccines/programs/iis/code-sets/vis-barcode-lookup-table.html</a></p><p><br><br><br></p></td></tr></table><br/>
		</div>
	</fieldset>
</body>
</html>